Announcements Trials

Browse Landscape

Phase

Phase 1 15 Phase 1/2 4 Phase 2 1

Status

Completed 5 Terminated 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 412 Carcinoma, Non-Small-Cell Lung 285 Prostatic Neoplasms 208 Neoplasms 202 Neoplasm Metastasis 179 Melanoma 164 Multiple Myeloma 158 Colorectal Neoplasms 157 Leukemia, Myeloid, Acute 143 Lung Neoplasms 132 Leukemia 126 Lymphoma 118 Pancreatic Neoplasms 117 Recurrence 111 Ovarian Neoplasms 111 Leukemia, Lymphocytic, Chronic, B-Cell 110 Lymphoma, Non-Hodgkin 104 Carcinoma, Renal Cell 104 Brain Neoplasms 89 Myelodysplastic Syndromes 88 Precursor Cell Lymphoblastic Leukemia-Lymphoma 86 Glioblastoma 84 Lymphoma, Large B-Cell, Diffuse 80 Lymphoma, Follicular 79 Carcinoma, Hepatocellular 79 Head and Neck Neoplasms 77 Squamous Cell Carcinoma of Head and Neck 76 Urinary Bladder Neoplasms 66 Stomach Neoplasms 61 Hodgkin Disease 59

Interventions

relatlimab 1 linrodostat 1 Nivolumab 1 Ipilimumab 1 Dasatinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Terminated × Advanced Cancer × Clear all

NCT02750514 2021-03-22

FRACTION-Lung

Bristol-Myers Squibb

Phase 2 Terminated

295 enrolled 21 charts

Advanced Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡